Analyst Questions AutoZone's Uptick Following F4Q Results -- Market Talk
Dow Jones2026/09/22 12:330833 ET - AutoZone shares are up in early trading, even after its F4Q same-store sales missed Wall Street estimates. An 8.6% sales increase in its domestic commercial business implies slightly negative same-store sales for its core do-it-yourself segment, Mizuho analyst David Bellinger says in a note, also mentioning that operating expenses were elevated, though offset by tariffs refunds. "We question shares initially up on this print," he says. The stock ticks up 1.3% premarket. (kelly.cloonan@wsj.com)
(END) Dow Jones Newswires
September 22, 2026 08:33 ET (12:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Bitcoin rebounds sharply from oversold levels, briefly surpassing $57,000

Masayoshi Son's Trillion-Dollar Gamble: Once Considered Acquiring SK Hynix
According to reports, Masayoshi Son once planned to acquire the South Korean memory chip giant SK Hynix for nearly 1 trillion US dollars and had approached Wall Street institutions to seek financing, but SoftBank has confirmed it is no longer actively pursuing the deal. The massive financing requirement and South Korean regulatory restrictions were major obstacles. This plan also highlights SoftBank’s further strategic intention to invest in AI storage chips.
"Sell-offs bring more sell-offs! Goldman Sachs predicts another large-scale sell-off in the U.S. stock market in the coming week."
Goldman Sachs stated that the bank’s “panic index” has risen to 9 out of 10, with systemic selling pressure continuing to spread. In the coming week, CTAs may sell up to $80.6 billion in US stocks, and even if the market remains flat, there is still $65.8 billion in sell orders waiting to be executed. The Anthropic IPO failed to boost market risk appetite, and concerns over AI investment returns continue to weigh on tech stock valuations.